Lupus in Germany: Analysis within the German lupus self-help organization (LULA);Lupus in Deutschland: Querschnittsanalyse innerhalb der lupus erythematodes selbsthilfegemeinschaft (LULA)

Zeitschrift fur Rheumatologie

Volumn 64, Issue 2, 2005, Pages 111-122

  Fischer Betz, R ^a   Wessel, E ^a   Richter, J ^a   Winkler Rohlfing, B ^b   Willers, R ^a   Schneider, M ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b Selbsthilfegemeinschaft E V   (Germany)

Author keywords

Cohort studies; Prognosis; Self documentation; Severity of illness; Systemic lupus erythematosus

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; HYDROXYCHLOROQUINE; HYDROCORTISONE; IMMUNOSUPPRESSIVE AGENT;

ARTICLE; COMORBIDITY; COMPARATIVE STUDY; DATA BASE; DEPRESSION; DISEASE SEVERITY; GERMANY; HEALTH CARE; HEALTH CARE ORGANIZATION; HEALTH STATUS; HEART INFARCTION; HUMAN; HYPERTENSION; KIDNEY DISEASE; LONG TERM CARE; LUPUS ERYTHEMATOSUS; MEDICAL CARE; MENTAL DISEASE; MORTALITY; OSTEOARTHRITIS; OSTEOPOROSIS; PREVALENCE; PROGNOSIS; SKIN DISEASE; STROKE; THROMBOEMBOLISM; ADULT; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; IMMUNOLOGY; INCIDENCE; MALE; MIDDLE AGED; PATIENT ATTITUDE; QUALITY OF LIFE; QUESTIONNAIRE; SELF HELP; STATISTICS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; COHORT STUDIES; COMORBIDITY; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GERMANY; HUMANS; HYDROCORTISONE; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRES; SELF-HELP GROUPS; SICK ROLE;

EID: 23844459351     PISSN: 03401855     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00393-005-0644-5     Document Type: Article

References (28)

1. Abu-Shakra M, Urowitz MB, Gladman DD, Gough J (1995) Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death. J Rheumatol 22(7): 1259-1264
2. Alarcon GS, McGwin G Jr, Petri M, Reveille JD, Ramsey-Goldman R, Kimberley RP for the PROFILE Study group (2002) Baseline characteristics of a multiethnic lupus cohort: PROFILE. Lupus 11:95-101
3. Boersma E, Keil U, De Bacquer D et al (2003) Blood pressure is insufficiently controlled in European patients with established coronary heart disease. J Hypertension 21:1831-1840
4. Cervera R, Khamashta M, Font J, Sebastiani GD, Gil A, Lavilla P et al (1993) Systemic Lupus Erythematosus: Clinical and Immunologic Patterns of Disease Expression in a Cohort of 1,000 Patients. Medicine 72 (2):113-124
5. Colditz GA, Martin P, Stampfer MJ, Willett WC, Sampson L, Rosner B, Hennekens CH, Speizer FE (1986) Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol 123(5):894-900
6. Friedman AW, Tewi MB, Ahn C, McGwin G Jr, Fessler BJ, Bastian HM, Baethge BA, Reveille JD, Alarcon GS; LUMINA Study Group (2003) Systemic lupus erythematosus in three ethnic groups: XV. Prevalence and correlates of fibromyalgia. Lupus 12(4):274-279
7. Gladman D, Ginzler E, Goldsmith C et al (1992) Systemic lupus international collaborative clinics: development of a damage index in systemic lupus erythematosus. J Rheumatol 19:1820-1821
8. Gladman DD, Urowitz MB, Rahman P, Ibanez D, Tam LS (2003) Accrual of organ damage over time in patients with systemic lupus erythematosus. J Rheumatol 30(9):1955-1959
9. Katz JN, Chang LC, Sangha O, Fossel AH, Bates DW (1996) Can comorbidity be measured by questionnaire rather than medical record review? Med Care 34(1):73-84
10. Linet MS, Harlow SD, McLaughlin JK, McCaffrey LD (1989) A comparison of interview data and medical records for previous medical conditions and surgery. J Clin Epidemiol 42(12):1207-1213
11. Lopez P, Mozo L, Gutierrez C, Suarez A (2003) Epidemiology of systemic lupus erythematosus in a northern Spanish population: gender and age influence on immunological features. Lupus 12(11):860-865
12. Manger K, Manger B, Repp R, Geisselbrecht M, Geiger A, Pfahlberg A, Harrer T, Kalden JR (2002) Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus. Ann Rheum Dis 61(12):1065-1070
13. Mechanic D (1980) The experience and reporting of common physical complaints. J Health Soc Behav 21(2):146-155
14. Middleton GD, McFarlin JE, Lipsky PE (1994) The prevalence and clinical impact of fibromyalgia in systemic lupus erythematosus. Arthritis Rheum 37(8):1181-1188
15. Nived O, Jonsen A, Bengtsson AA, Bengtsson C, Sturfelt G (2002) High predictive value of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for survival in systemic lupus erythematosus. J Rheumatol 29(7):1398-1400
16. Partridge AJ, Karlson EW, Daltroy LH, Lew RA, Wright EA, Fossel AH, Straaton KV, Stern SH, Kavanaugh AF, Roberts WN, Liang MH (1997) Risk factors for early work disability in systemic lupus erythematosus: results from a multicenter study. Arthritis Rheum 40(12):2199-2206
17. Reveille JD, Moulds JM, Ahn C, Friedman AW, Baethge B, Roseman J, Straaton KV, Alarcon GS (1998) Systemic lupus erythematosus in three ethnic groups: I. The effects of HLA class II, C4, and CR1 alleles, socioeconomic factors, and ethnicity at disease onset. LUMINA Study Group. Lupus in minority populations, nature versus nurture. Arthritis Rheum 41(7):1161-1172
18. Rivest C, Lew RA, Welsing PM, Sangha O, Wright EA, Roberts WN, Liang MH, Karlson EW (2000) Association between clinical factors, socioeconomic status, and organ damage in recent onset systemic lupus erythematosus. J Rheumatol 27(3):680-684
19. Sangha O, Stucki G, Liang MH, Fossel AH, Katz JN (2003) The Self-Administered Comorbidity Questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheum 15; 49(2):156-163
20. Stahl-Hellengren C, Jonsen A, Nived O, Sturfelt G (2000) Incidence studies of systemic lupus erythematosus in Southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis. J Rheumatol 27(3):685-691
21. Statistisches Bundesamt (2001) Bevölkerung und Erwerbstä tigkeit. Ergebnisse des Mikrozensus. Wiesbaden, 2002
22. Swaak AJ, van den Brink HG, Smeenk RJ, Manger K, Kalden JR, Tosi S, Marchesoni A, Domljan Z, Rozman B, Logar D, Pokorny G, Kovacs L, Kovacs A, Vlachoyiannopoulos PG, Moutsopoulos HM, Chwalinska-Sadowska H, Dratwianka B, Kiss E, Cikes N, Branimir A, Schneider M, Fischer R, Bombardieri S, Mosca M, Smolen JS et al (1999) Systemic lupus erythematosus: clinical features in patients with a disease duration of over 10 years, first evaluation. Rheumatology (Oxford) 38(10):953-958
23. Takada K, Illei GG, Boumpas DT (2001) Cyclophosphamide for the treatment of systemic lupus erythematosus. Lupus10(3):154-161
24. Urowitz MB, Gladman DD (1999) Evolving spectrum of mortality and morbidity in SLE. Lupus 8(4):253-255
25. Ward MM, Pyun E, Studenski S (1995) Long-term survival in systemic lupus erythematosus. Patient characteristics associated with poorer outcomes. Arthritis Rheum 38:274-283
26. Wolf-Maier K, Cooper RS, Banegas JR et al (2003) Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 289:2363-2369
27. Zink A (1995) Epidemiologie der rheumatologischen Versorgung in Deutschland. Z Rheumatol 54:184-191
28. Zink A, Fischer-Betz R, Thiele K, Listing J, Huscher D, Gromnica-Ihle E, Specker C, Schneider M for the German Collaborative Arthritis Centres (2004) Health care and burden of illness in SLE compared to RA. Results from the national database of the German Collaborative Arthritis Centres (Lupus, in press)